Reduced-intensity conditioning and stem cell transplantation in infants with Diamond Blackfan anemia

Haematologica. 2017 Mar;102(3):e73-e75. doi: 10.3324/haematol.2016.157149. Epub 2016 Dec 7.

Authors

Roman Crazzolara^{1

2}, Gabriele Kropshofer³, Oskar A Haas^{4

5}, Susanne Matthes-Martin⁴, Leo Kager^{4

5}

Affiliations

¹ Department of Pediatrics, Medical University Innsbruck, Austria roman.crazzolara@i-med.ac.at.
² Tyrolean Cancer Research Institute, Innsbruck, Austria.
³ Department of Pediatrics, Medical University Innsbruck, Austria.
⁴ St. Anna Children's Hospital, Department of Pediatrics, Medical University Vienna, Austria.
⁵ Children's Cancer Research Institute, Austria.

No abstract available

Publication types

Case Reports
Letter
Multicenter Study

MeSH terms

Anemia, Diamond-Blackfan / immunology
Anemia, Diamond-Blackfan / pathology
Anemia, Diamond-Blackfan / therapy*
Busulfan / analogs & derivatives
Busulfan / therapeutic use
Hematopoietic Stem Cell Transplantation*
Humans
Infant
Infant, Newborn
Male
Myeloablative Agonists / therapeutic use*
Thiotepa / therapeutic use
Transplantation Conditioning / methods*
Treatment Outcome
Vidarabine / analogs & derivatives
Vidarabine / therapeutic use

Substances

Myeloablative Agonists
Thiotepa
treosulfan
Vidarabine
Busulfan
fludarabine